Funnelfeedr Logo

Disruptive Pharma AB (publ)

Sverige556755-3226Active

Swedish biotech developing novel kidney disease therapies based on proprietary peptides.

Biotechnology Companyguardtherapeutics.com

Oversigt

5–9
Medarbejdere
≤1t SEK
Omsætning
2008
Grundlagt

Nøglebeslutningstagere

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

+9 flere kontakter i Funnelfeedr

Beskrivelse

Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...

Tags

B2BHealthcarePharmaceuticalsProfessional ServicesPublicly ListedTechnologyWhite Collar

Nøgleord

BiotechnologyClinical StageDrug DevelopmentKidney DiseasePharmaRMC-035

Teknologistak

YiijQueryVimeoBootstrapCraft CMSFont AwesomeModernizrPHP

Virksomhedsoplysninger

Branche
Annan naturvetenskaplig och teknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE556755322601

Beslutningstagere

13 kontakter i Funnelfeedr

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

Sara Thuresson

Head of Clinical Operations

Fredrik Lehmann

Board Member

Göran Forsberg

Board Member

Johannes Hulthe

Board Member

Michael Reusch

CMO

Johan Bygge

Chairman of the Board

Hege Hellström

Board Member

Peter Gilmour

Head of Preclinical Science

Andre kontakter

Mikael Widell

IR Contact

@guardtherapeutics.com

Lignende virksomheder

20 lignende virksomheder i Funnelfeedr

Udforsk mere

Spørgsmål om Disruptive Pharma AB (publ)

Vil du se Funnelfeedr i aktion?

Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.

Book en demo